Breakthrough cancer pain: Rapid-onset opioids or short-acting opioids?
Published 28th April 2023
When selecting an appropriate opioid treatment for BTcP, it is important to consider the pharmacokinetic properties of the treatment.
References
- Davies AN et al. Eur J Pain 2009;13(4):331–8.
- Davies A et al. J Pain Symptom Manag 2013;46(5):619–28.
- Vellucci R et al. Drugs 2016;76:315–30.
- Simon SM et al. J Opioid Manag 2014;10:207–15.
- World Health Organization. Cancer Pain Relief. World Health Organization, 1986.
Available from: https://apps.who.int/iris/bitstream/handle/10665/43944/9241561009_eng.pdf - Smith HS. Ann Palliat Med 2012;1(1):45–52.